AstraZeneca AB et al v. Alembic Pharmaceuticals Ltd. et al > Summary
Court Case Number 1:22-cv-01216
Filing Date Sep 16, 2022
Termination Date Dec 30, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Plaintiff
Plaintiff Attorneys
8AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
Defendant Attorneys
2Related Patents
Doc No | Title | Issue date |
---|---|---|
10300065 | Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction | May 28, 2019 |